Artigo Acesso aberto Revisado por pares

Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study

2014; Oxford University Press; Volume: 36; Issue: 6 Linguagem: Inglês

10.1093/eurheartj/ehu178

ISSN

1522-9645

Autores

Martin Möckel, Julia Searle, Christian W. Hamm, Anna Slagman, Stefan Blankenberg, Kurt Huber, Hugo A. Katus, Christoph Liebetrau, Christian Müller, Reinhold Müller, Philipp Peitsmeyer, Johannes von Recum, Miloš Tajsić, J. Vollert, Evangelos Giannitsis,

Tópico(s)

Atrial Fibrillation Management and Outcomes

Resumo

AimsThis randomized controlled trial (RCT) evaluated whether a process with single combined testing of copeptin and troponin at admission in patients with low-to-intermediate risk and suspected acute coronary syndrome (ACS) does not lead to a higher proportion of major adverse cardiac events (MACE) than the current standard process (non-inferiority design).

Referência(s)